Odyssey Health, Inc. (ODYY) Fair Value 2026

ODYY · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

3.7 /10

32 fundamental signals · 1 models active

Value Trap Risk

LOW (34/100)

Quick Summary — As of 2026-08-27, Odyssey Health, Inc. (ODYY) trades at $0.01. QOC: 3.7/10. Value Trap Risk: 34/100 (LOW). 1/13 models active.

Key Facts

Ticker
ODYY
Price
$0.01
Quality Score
3.7/10
Value Trap Risk
34/100
Models Active
1/13
Last Updated
Strength: 1 independent models provide multi-angle coverage
Risk: Below-average Quality Score of 3.7/10 signals weak fundamentals

What Fair Value Does Each Model Give ODYY?

1 Intrinsic Value Models vs. Current Price ($0.01)

Core Models (Unlocked)
Model Fair Value Upside
Option-Based · Low Conviction
 $0.00 -98.3%

All Models Active

All 1 models are displayed above.

What Is Odyssey Health, Inc. (ODYY) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Odyssey Health, Inc.'s intrinsic value is estimated at $0.00, suggesting the stock is overvalued at its current price of $0.01. With 1 out of 1 models flagging downside (-98.3% vs price), the market may be pricing in unsustainable growth.

What Do the Models Say About ODYY?

1 of 13 models are currently active for ODYY. All 1 active models suggest the stock trades above fair value. See which stocks rank higher →

How Does ODYY Rank in Medical Devices?

Among 157 Medical Devices stocks, ODYY ranks #149 by Quality of Company score. CirclFi's QOC score of 3.7/10 evaluates 32 fundamental signals. A score of 3.7 signals below-average fundamentals.

See all Most Undervalued Medical Devices Stocks →

Within the Medical Devices space, Odyssey Health, Inc. competes in an environment where clinical trial success rate often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is ODYY a Value Trap?

CirclFi's Value Trap algorithm assigns ODYY a score of 34/100 (LOW). This indicates low risk. The financial profile does not exhibit typical value trap warning signs. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

1 of 13 models are active for Odyssey Health, Inc.. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Odyssey Health, Inc. is rated at 3.7/10. This moderate-tier score shows mixed signals across our quality framework with notable weaknesses.

CirclFi runs 13 independent models for each stock. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ODYY valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ODYY's 1 active models, average confidence is 5%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Odyssey Health, Inc. Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

11 related Medical Devices stocks with 13-model coverage

STMESTIMCELL ENERGETICS INC.QOC 3.7GCTKGlucoTrack, Inc.QOC 3.6LUDGLudwig Enterprises, Inc.QOC 3.7LMRILumexa Imaging Holdings, Inc.QOC 3.5ALMRAlamar Biosciences, Inc.QOC 3.8RTGNRetinalGenix Technologies Inc.QOC 3.5BIOBio-Rad Laboratories, Inc.QOC 7.8CLPTClearPoint Neuro, Inc.QOC 6.5PLSMPulsenmore Ltd.QOC 5.6IRMDIRADIMED CORPORATIONQOC 9.8PODDInsulet CorporationQOC 9.6

Read investment analysis: STME · GCTK · LUDG · LMRI · ALMR · RTGN · BIO · CLPT · PLSM · IRMD · PODD

Which Other Stocks Have a Similar Quality Score to ODYY?

7 companies across all industries closest to ODYY’s Quality of Company score of 3.7/10.

RNAAtrium Therapeutics, Inc.QOC 3.7NICMNicola Mining Inc.QOC 3.7LBSRLiberty Star Uranium & Metals Corp.QOC 3.7GLUCGlucose Health, Inc.QOC 3.7KALAKALA BIO, Inc.QOC 3.7HWKEHawkeye Systems, Inc.QOC 3.7NVDANVIDIA CorporationQOC 10.0

Read investment analysis: RNA · NICM · LBSR · GLUC · KALA · HWKE · NVDA

Where Does ODYY Sit in CirclFi's Medical Devices Rankings?

ODYY is ranked against every other Medical Devices stock CirclFi covers in each of these screens.

See all Medical Devices stocks ranked →

What Else Do Investors Ask About Odyssey Health, Inc.’s Valuation?

What is Odyssey Health, Inc.'s intrinsic value in 2026?

CirclFi does not yet have enough active models to publish a median fair value for Odyssey Health, Inc. (ODYY). The Quality of Company score is 3.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ODYY overvalued or undervalued right now?

At $0.01, 0 of 1 active models suggest ODYY may be undervalued, while 1 indicate potential overvaluation. The assessment depends on which methodology best fits Odyssey Health, Inc.'s business model in Medical Devices.

What does a Quality of Company score of 3.7 mean for ODYY?

Odyssey Health, Inc.'s QOC of 3.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores below 5 flag potential fundamental weaknesses requiring careful analysis.

How many valuation models does CirclFi run on ODYY?

CirclFi analyzes ODYY with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 1 of 13 are active for this stock. Read the full methodology →

Is ODYY a value trap in 2026?

Odyssey Health, Inc.'s Value Trap score is 34/100 (LOW). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

Cite this analysis — “CirclFi assigns Odyssey Health, Inc. (ODYY) a Quality of Company score of 3.7/10 across 32 fundamental signals as of 2026-08-27.” Source: circlfi.com/stock/ODYY/ · Methodology
Primary sources for this ODYY valuation
  • Financial statements: Odyssey Health, Inc. 10-K and 10-Q filings on SEC EDGAR (CIK 0001626644) — 700+ standardized XBRL tags, published by the U.S. Securities and Exchange Commission.
  • Discount-rate inputs: FRED, Federal Reserve Bank of St. Louis — risk-free rates, VIX, yield curve, inflation.
  • News sentiment: The GDELT Project — global media tone, input to the Sentiment SOTP model.
  • Model definitions: CirclFi methodology — the published specification for all 13 models, including the academic sources each one implements.

Market data for ODYY as of ; valuations recomputed .